Preliminary VC Deal Data Shows Mixed Bag
Venture capitalists invested $2.94 billion into 360 U.S.-based companies during the second quarter, according to preliminary, unaudited data from Thomson Reuters (publisher of peHUB). That’s down significantly from the $7.57 billion investors put into 1,042 companies during the same period in 2008, although is beginning to approach the $3.1 billion invested in Q1 2009 (and will probably top it, once all the surveys are counted). The official MoneyTree report from the National Venture Capital Association and PricewaterhouseCoopers, based on Thomson Reuters data, is expected to come out later this month. Biotechnology and health care investments buoyed the investment totals in Q2, accounting for nearly 45% of the dollars put to work during the three-month period. Four of the 10 largest deals done the quarter were health care deals. Investors put $145 million into anti-cancer company Clovis Oncology; $108 million into orthopedics company Small Bone Innovations; $50 million into light-therapy company PhotoThera; and $46 million into anti-infective medicine developer Cempra Pharmaceuticals.
